ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2308건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2175 | Completed | A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19) | SARS-CoV-2 Infection (COVID-19) | Drug: FOY-305 Drug: Placebo |
Phase 3 | Ono Pharmaceutical Co. Ltd | INDUSTRY | 155 | All | 18 Years | Aichi Clinical Site 1, Tokoname, Aichi, Japan Chiba Clinical Site 1, Narita, Chiba, Japan Fukuoka Clinical Site 1, Okawa, Fukuoka, Japan Ibaraki Clinical Site 1, Tsuchiura, Ibaraki, Japan Ishikawa Clinical Site 1, Kanazawa, Ishikawa, Japan Kanagawa Clinical Site 3, Kawasaki, Kanagawa, Japan Kanagawa Clinical Site 1, Yokohama, Kanagawa, Japan Kanagawa Clinical Site 2, Yokosuka, Kanagawa, Japan Mie Clinical Site 1, Yokkaichi, Mie, Japan Niigata Clinical Site 1, Nagaoka, Niigata, Japan Osaka Clinical Site 2, Daito, Osaka, Japan Saitama Clinical Site 3, Kawagoe, Saitama, Japan Saitama Clinical Site 1, Kuki, Saitama, Japan Saitama Clinical Site 2, Kumagaya, Saitama, Japan Tokyo Clinical Site 5, Bunkyo-ku, Tokyo, Japan Tokyo Clinical Site 9, Bunkyo-ku, Tokyo, Japan Tokyo Clinical Site1, Hachioji, Tokyo, Japan Tokyo Clinical Site 7, Itabashi-ku, Tokyo, Japan Tokyo Clinical Site 3, Meguro-ku, Tokyo, Japan Tokyo Clinical Site 4, Shinagawa-ku, Tokyo, Japan Tokyo Clinical Site 8, Sibuya-ku, Tokyo, Japan Tokyo Clinical Site2, Sibuya-ku, Tokyo, Japan Tokyo Clinical Site 6, Tachikawa, Tokyo, Japan Okayama Clinical Site 1, Okayama, Japan Osaka Clinical Site 1, Osaka, Japan |
| 2174 | Completed | A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 | COVID-19 | Drug: BRII-196 and BRII-198 Drug: Placebo |
Phase 2 | Brii Biosciences Limited, TSB Therapeutics (Beijing) CO.LTD | INDUSTRY | 48 | All | 18 Years | Beijing Ditan Hospital Capital Medical University, Beijing, Beijing, China Guangzhou Eighth Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China The Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China Subei People's Hospital of Jiangsu province, Yangzhou, Jiangsu, China Yunnan Provincial Infectious Disease Hospital, Kunming, Yunnan, China |
| 2173 | Unknown status | A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers | COVID19 | Drug: Hydroxychloroquine Drug: Hydroxychloroquine (placebo) Drug: Zinc Drug: Zinc (Placebo) |
Phase 3 | Military Hospital of Tunis, UR17DN02 : Autoimmune Diseases Research Unit, Dacima Consulting | OTHER | 660 | All | 18 Years ~ 65 Years | Military Hospital of Tunis, Tunis, Tunisia |
| 2172 | Terminated | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | Cancer | Drug: Hydroxychloroquine Other: Placebo Radiation: Radiation therapy |
Phase 2 | Memorial Sloan Kettering Cancer Center | OTHER | 4 | All | 18 Years | Memoral Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States Memorial Sloan Kettering Bergen (All protocol Activities), Montvale, New Jersey, United States Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States Memoral Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States |
| 2171 | Recruiting | A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | Coronavirus 19 | Drug: Hydroxychloroquine Dietary Supplement: Vitamin C Dietary Supplement: Vitamin D Dietary Supplement: Zinc |
Phase 2 | ProgenaBiome, DSCS CRO | OTHER | 600 | All | 18 Years | ProgenaBiome, Ventura, California, United States |
| 2170 | Completed | A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness | COVID-19 | Drug: Bamlanivimab Drug: Etesevimab Drug: Placebo Drug: VIR-7831 Drug: Bebtelovimab |
Phase 2 | Eli Lilly and Company, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd., GlaxoSmithKline, Vir Biotechnology, Inc. | INDUSTRY | 1755 | All | 12 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States The Institute for Liver Health, Mesa, Arizona, United States Perseverance Research Center, Scottsdale, Arizona, United States CRI of Arizona, LLC, Sun City West, Arizona, United States Fiel Family and Sports Medicine PC, Tempe, Arizona, United States The Institute for Liver Health, Tucson, Arizona, United States KLR Business Group, Inc. dba Arkansas Clinical Research, Little Rock, Arkansas, United States Applied Rsch Ctr - Arkansas Inc., Little Rock, Arkansas, United States Smart Cures Clin Research, Anaheim, California, United States Hope Clinical Research, Canoga Park, California, United States VCT-Covina, Covina, California, United States Neighborhood Healthcare, Escondido, California, United States Chemidox Clinical Trials, Lancaster, California, United States Ark Clinical Research, Long Beach, California, United States Long Beach Clinical Trials LLC, Long Beach, California, United States Cedars Sinai Medical Center, Los Angeles, California, United States Central Valley Research, LLC, Modesto, California, United States Inland Empire Liver Foundation, Rialto, California, United States Sutter Institute For Medical Research, Sacramento, California, United States Wolverine Clinical Trials, LLC, Santa Ana, California, United States St. Joe Heritage HC-Santa Rosa, Santa Rosa, California, United States Stanford University Hospital, Stanford, California, United States Mazur, Statner, Dutta, Nathan, Thousand Oaks, California, United States South Bay Clinical Research Institute, Torrance, California, United States Infect Disease Doctors Med Grp, Walnut Creek, California, United States Allianz Research Institute, Westminster, California, United States Future Innovative Treatments LLC, Colorado Springs, Colorado, United States Georgetown Univ Sch of Med, Washington, District of Columbia, United States Synergy Healthcare LLC, Bradenton, Florida, United States Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States I R & Health Center, Inc., Hialeah, Florida, United States Encore Medical Research, Hollywood, Florida, United States Elixia CRC, Hollywood, Florida, United States Lakeland Regional Medical Center, Lakeland, Florida, United States Panax Clinical Research, Miami Lakes, Florida, United States Hope Clinical Trials, Inc., Miami, Florida, United States Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States Bio-Medical Research, LLC, Miami, Florida, United States Clinical Site Partners, LLC d/b/a CSP Miami, Miami, Florida, United States Testing Matters Lab, Sunrise, Florida, United States Advent Health Tampa, Tampa, Florida, United States Triple O Research Inst, West Palm Beach, Florida, United States Encore Medical Research - Weston, Weston, Florida, United States Clinical Site Partners, LLC DBA CSP Orlando, Winter Park, Florida, United States Gwinnett Research Inst, Buford, Georgia, United States Paramount Rch Sol - College Pk, College Park, Georgia, United States IACT Health - VHC, Columbus, Georgia, United States Central Georgia Infectious Disease, Macon, Georgia, United States Rophe Adult and Pediatric Medicine, Union City, Georgia, United States Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States Great Lakes Clinical Trials, Chicago, Illinois, United States Franciscan Health Hammond, Dyer, Indiana, United States Qualmedica Research Evansville, Evansville, Indiana, United States Franciscan St. Francis Health, Indianapolis, Indiana, United States St.Vincent - Indy, Indianapolis, Indiana, United States Qualmedica Research, LLC, Owensboro, Kentucky, United States Tandem Clinical Research,LLC, Marrero, Louisiana, United States Imperial Health Urgent Care Center - Moss Bluff, Moss Bluff, Louisiana, United States Nola Research Works, LLC, New Orleans, Louisiana, United States University of Maryland Medical Center, Baltimore, Maryland, United States Massachusetts General Hospital, Boston, Massachusetts, United States U of MA Mem Med Ctr, Worcester, Massachusetts, United States University of Michigan, Ann Arbor, Michigan, United States Great Lakes Research Group, Inc., Bay City, Michigan, United States Revive Research Institute, Farmington Hills, Michigan, United States Revival Research Institute, Sterling Heights, Michigan, United States Sky Clinical Prime and Health Wellness Clinic, Fayette, Mississippi, United States Olive Branch Family Medical Center, Olive Branch, Mississippi, United States Sky Clin Resch - Quinn HC, Ridgeland, Mississippi, United States Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States Quality Clinical Research, Omaha, Nebraska, United States Excel Clinical Research, Las Vegas, Nevada, United States Las Vegas Medical Research, Las Vegas, Nevada, United States SVG Clinical, Las Vegas, Nevada, United States Holy Name Medical Center, Teaneck, New Jersey, United States Prime Global Research, LLC, Bronx, New York, United States Onsite Clinical Solutions, LLC, Charlotte, North Carolina, United States East Carolina University, Greenville, North Carolina, United States Monroe Biomed Research, Monroe, North Carolina, United States Carteret Medical Group, Morehead City, North Carolina, United States PMG Research of Wilmington, Wilmington, North Carolina, United States Valley Medical Primary Care, Centerville, Ohio, United States Hometown UC and Rch- Cincy, Cincinnati, Ohio, United States Aventiv Research Inc, Columbus, Ohio, United States Urgent Care Specialists, LLC, Columbus, Ohio, United States Remington-Davis, Inc, Columbus, Ohio, United States Urgent Care Specialists, LLC, Dayton, Ohio, United States META Medical Research Institute, Dayton, Ohio, United States Ascension St. John Tulsa OK, Tulsa, Oklahoma, United States Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States Jefferson Hosp for Neurosci, Philadelphia, Pennsylvania, United States Temple University Hospital, Philadelphia, Pennsylvania, United States VITALINK - Anderson, Anderson, South Carolina, United States Carolina Medical Research - Clinton, Clinton, South Carolina, United States VITALINK - Gaffney, Gaffney, South Carolina, United States Carolina Medical Research - Greenville, Greenville, South Carolina, United States VITALINK - Greenville, Greenville, South Carolina, United States VITALINK - Spartanburg, Spartanburg, South Carolina, United States VITALINK - Union, Union, South Carolina, United States Univ Diab & Endo Consult, Chattanooga, Tennessee, United States New Phase Research and Development, Knoxville, Tennessee, United States Gadolin Research, LLC, Beaumont, Texas, United States Conroe Willis Medical Research, Conroe, Texas, United States Crossroads Clinical Research, Corpus Christi, Texas, United States B S & W Med Center, Dallas, Texas, United States Baylor - Fort Worth, Fort Worth, Texas, United States North Texas Clinical Trials, LLC, Fort Worth, Texas, United States Houston Methodist Research Ins, Houston, Texas, United States Next Level Urgent Care, Houston, Texas, United States Accurate Clinical Management, LLC., Houston, Texas, United States 1960 Family Practice, PA, Houston, Texas, United States B S & W Med Center, Irving, Texas, United States Zion Urgent Care Clinic, Katy, Texas, United States BioPharma Family Practice Center McAllen, McAllen, Texas, United States BRCR Medical Center, Inc, McAllen, Texas, United States North Hills Medical Research, North Richland Hills, Texas, United States Bay Area Infectious Diseases Associates, Pasadena, Texas, United States Epic Medical Research, Red Oak, Texas, United States Baylor - Round Rock, Round Rock, Texas, United States Sun Research Institute, San Antonio, Texas, United States Consano Clinical Research, LLC, Shavano Park, Texas, United States APD Clinical Research, Splendora, Texas, United States Crossroads Clin Rch-Victoria, Victoria, Texas, United States CLS Research Ctr, PLLC, Webster, Texas, United States CARE ID, Annandale, Virginia, United States Evergreen Health Research, Kirkland, Washington, United States Sanatorio Sagrado Corazon, Ciudad de Buenos Aires, AR, Argentina Clinica Zabala, Ciudad de Buenos Aires, AR, Argentina Sanatorio de la Trinidad Mitre, Caba, Buenos Aires, Argentina Clinica Privada Independencia, Munro, Buenos Aires, Argentina Go Centro Medico San Nicolas, San Nicolas, Buenos Aires, Argentina Instituto de Investigaciones Clinicas Zarate, Zarate, Buenos Aires, Argentina Instituto Medico Rio Cuarto, Rio Cuarto, Cordoba, Argentina Clinica Central S.A., Villa Regina, Rio Negro, Argentina Centro de Investigaciones Clinicas - Clinica Viedma, Viedma, RN, Argentina INECO Neurociencias Orono, Rosario, Santa Fe, Argentina Hospital San Roque, Cordoba, Argentina Advanced Clinical Research, LLC, Bayamon, Puerto Rico Dorado Medical Complex Inc, Dorado, Puerto Rico GCM Medical Group, PSC - Hato Rey Site, San Juan, Puerto Rico |
| 2169 | Terminated | A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19 | Covid19 | Biological: Ampion Other: Placebo |
Phase 2 | Ampio Pharmaceuticals. Inc. | INDUSTRY | 200 | All | 18 Years | Ampio Pharmaceuticals, Englewood, Colorado, United States |
